LWA
Lineweaver Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
3,085
-178
| -5% | -$72.2K | 0.2% | 86 |
|
|
2025
Q1 | $1.62M | Buy |
3,263
+71
| +2% | +$35.3K | 0.28% | 75 |
|
|
2024
Q4 | $1.66M | Buy |
3,192
+1,568
| +97% | +$816K | 0.31% | 64 |
|
|
2024
Q3 | $1.01M | Sell |
1,624
-28
| -2% | -$17.3K | 0.19% | 83 |
|
|
2024
Q2 | $914K | Buy |
1,652
+58
| +4% | +$32.1K | 0.19% | 83 |
|
|
2024
Q1 | $927K | Sell |
1,594
-6
| -0.4% | -$3.49K | 0.22% | 83 |
|
|
2023
Q4 | $850K | Sell |
1,600
-87
| -5% | -$46.2K | 0.22% | 82 |
|
|
2023
Q3 | $854K | Buy |
1,687
+21
| +1% | +$10.6K | 0.25% | 67 |
|
|
2023
Q2 | $869K | Sell |
1,666
-16
| -1% | -$8.35K | 0.25% | 69 |
|
|
2023
Q1 | $970K | Sell |
1,682
-9
| -0.5% | -$5.19K | 0.3% | 65 |
|
|
2022
Q4 | $931K | Sell |
1,691
-71
| -4% | -$39.1K | 0.28% | 69 |
|
|
2022
Q3 | $891K | Buy |
1,762
+75
| +4% | +$37.9K | 0.29% | 62 |
|
|
2022
Q2 | $916K | Sell |
1,687
-1,138
| -40% | -$618K | 0.3% | 59 |
|
|
2022
Q1 | $1.67M | Buy |
2,825
+55
| +2% | +$32.5K | 0.48% | 42 |
|
|
2021
Q4 | $1.85M | Sell |
2,770
-49
| -2% | -$32.7K | 0.53% | 34 |
|
|
2021
Q3 | $1.61M | Buy |
2,819
+1,198
| +74% | +$684K | 0.49% | 37 |
|
|
2021
Q2 | $818K | Buy |
1,621
+34
| +2% | +$17.2K | 0.27% | 56 |
|
|
2021
Q1 | $724K | Buy |
1,587
+322
| +25% | +$147K | 0.26% | 53 |
|
|
2020
Q4 | $589K | Buy |
1,265
+103
| +9% | +$48K | 0.23% | 49 |
|
|
2020
Q3 | $513K | Buy |
1,162
+145
| +14% | +$64K | 0.23% | 51 |
|
|
2020
Q2 | $368K | Buy |
1,017
+84
| +9% | +$30.4K | 0.19% | 54 |
|
|
2020
Q1 | $272K | Buy |
+933
| New | +$272K | 0.17% | 60 |
|